Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Vagner

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Molecular Imaging and Biology|January 22, 2015
A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the PancreasLeah V Steyn, Kameswari Ananthakrishnan, Miranda J Anderson, et al.
Peptides|August 7, 2010
Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptorsAlexander V Mayorov, Minying Cai, Erin S Palmer, et al.
American Journal of Physiology. Cell Physiology|August 1, 2019
The lipidated connexin mimetic peptide SRPTEKT-<i>Hdc</i> is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoformMaura L Cotter, Scott Boitano, Paul D Lampe, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Heterobivalent ligands crosslink multiple cell-surface receptors--a step towards personal medicineJatinder S Josan, Rajesh Sankaranarayanan, Heather L Handl, et al.
Bioconjugate Chemistry|October 22, 2015
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In VivoAllison S Cohen, Renata Patek, Steven A Enkemann, et al.
Pain|February 10, 2016
Neuroligin 2 regulates spinal GABAergic plasticity in hyperalgesic priming, a model of the transition from acute to chronic painJi-Young V Kim, Salim Megat, Jamie K Moy, et al.
DNA Repair|May 1, 2016
A novel small molecule inhibitor of the DNA repair protein Ku70/80Eric Weterings, Alfred C Gallegos, Lauren N Dominick, et al.
The Journal of Pain|November 23, 2022
C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in MiceMoeno Kume, Ayesha Ahmad, Stephanie Shiers, et al.
Bioconjugate Chemistry|November 16, 2006
Rigid linkers for bioactive peptidesJosef Vagner, Heather L Handl, Yasunari Monguchi, et al.
Bioconjugate Chemistry|November 3, 2012
Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligandNarges K Tafreshi, Xuan Huang, Valerie E Moberg, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Molecular Imaging and Biology|January 22, 2015
A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the PancreasLeah V Steyn, Kameswari Ananthakrishnan, Miranda J Anderson, et al.
Peptides|August 7, 2010
Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptorsAlexander V Mayorov, Minying Cai, Erin S Palmer, et al.
American Journal of Physiology. Cell Physiology|August 1, 2019
The lipidated connexin mimetic peptide SRPTEKT-<i>Hdc</i> is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoformMaura L Cotter, Scott Boitano, Paul D Lampe, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Heterobivalent ligands crosslink multiple cell-surface receptors--a step towards personal medicineJatinder S Josan, Rajesh Sankaranarayanan, Heather L Handl, et al.
Bioconjugate Chemistry|October 22, 2015
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In VivoAllison S Cohen, Renata Patek, Steven A Enkemann, et al.
Pain|February 10, 2016
Neuroligin 2 regulates spinal GABAergic plasticity in hyperalgesic priming, a model of the transition from acute to chronic painJi-Young V Kim, Salim Megat, Jamie K Moy, et al.
DNA Repair|May 1, 2016
A novel small molecule inhibitor of the DNA repair protein Ku70/80Eric Weterings, Alfred C Gallegos, Lauren N Dominick, et al.
The Journal of Pain|November 23, 2022
C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in MiceMoeno Kume, Ayesha Ahmad, Stephanie Shiers, et al.
Bioconjugate Chemistry|November 16, 2006
Rigid linkers for bioactive peptidesJosef Vagner, Heather L Handl, Yasunari Monguchi, et al.
Bioconjugate Chemistry|November 3, 2012
Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligandNarges K Tafreshi, Xuan Huang, Valerie E Moberg, et al.
Pageof 8